Subodh Kumar | Neuroscience | Best Researcher Award

Published on by Forensic Scientist

Assist. Prof. Dr. Subodh Kumar | Neuroscience | Best Researcher Award

Texas Tech University Health Sciences Center El Paso | United States

Dr. Subodh Kumar is an esteemed Assistant Professor in the Department of Molecular and Translational Medicine at Texas Tech University Health Sciences Center (TTUHSC), El Paso, USA. With a strong foundation in molecular biology and neurobiology, Dr. Kumar’s research centers around understanding the molecular underpinnings of neurodegenerative diseases, particularly Alzheimer’s disease (AD). He has made significant strides in uncovering the roles of synaptosomal and mitochondrial microRNAs in synaptic dysfunction and cognitive decline. A prolific researcher and innovator, Dr. Kumar has also contributed to biomarker discovery, therapeutic target identification, and translational neuroscience using cutting-edge multi-omics approaches.

Professional profile👤

Google Scholar

Scopus

Strengths for the Awards✨

Dr. Subodh Kumar has established an enviable track record of original, high-impact research that squarely meets—and arguably exceeds—the criteria for a “Best Researcher” distinction. His laboratory was first to profile synapse-localized microRNAs in the human brain and to link their deregulation to Alzheimer’s disease (AD), opening a fresh mechanistic window on synaptic failure. That foundational discovery has already yielded four first- or corresponding-author papers in top-tier journals since 2024 (e.g., Molecular Psychiatry and Clinical & Translational Medicine) and a growing citation trajectory.

Concurrently, Dr. Kumar has secured competitive funding as PI on an NIH K99/R00 Pathway to Independence Award, an R00 project running through 2026, and multiple foundation and intramural grants—clear evidence of both scientific rigor and fiscal stewardship. His service portfolio is equally compelling: associate editor for the Journal of Alzheimer’s Disease, ad-hoc reviewer for NIH, AHA, and international agencies, and manuscript referee for leading journals such as Nature Communications. Collectively, these achievements demonstrate innovation, productivity, leadership, and an ability to translate ideas into funded, peer-validated science—key hallmarks of an award-worthy researcher.

🎓 Education

Dr. Kumar’s academic journey began with a B.Sc. in Biology (2004) and an M.Sc. in Biotechnology (2005) from CCS University, Meerut, India. He earned his Ph.D. in Molecular Biology from the Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India, in 2014. Furthering his expertise, he completed postdoctoral training in Neurobiology at TTUHSC, Lubbock, Texas, USA, in 2021. His education spans across premier institutions in India and the United States, equipping him with a solid interdisciplinary background.

🧪 Experience

Dr. Kumar holds a distinguished career spanning academia and research. He is currently an Assistant Professor at TTUHSC El Paso (2022–present) and previously served as a Research Assistant Professor and Postdoctoral Fellow at TTUHSC Lubbock. His research roots trace back to roles at PGIMER and IIMT College of Medical Science in India. He has also held influential editorial roles and served as an ad-hoc reviewer for NIH and international grant agencies. With over 15 years in scientific research, Dr. Kumar has shaped the fields of neurobiology and molecular medicine through his multifaceted experience.

🧠 Research Interests On Neuroscience

Dr. Kumar’s research is dedicated to elucidating the roles of synaptic and mitochondrial microRNAs in neurodegeneration, especially in Alzheimer’s and Parkinson’s diseases. His lab explores miRNA-mediated modulation of synaptic proteins, neurotransmission, and mitochondrial health using advanced in vivo models and omics platforms. Current projects focus on miR-502-3p as a biomarker and therapeutic target in AD, including studies in Hispanic populations. His research portfolio spans synapse plasticity, GABAergic signaling, multi-omics integration, and biomarker validation in human and animal models.

🏅 Awards

Dr. Kumar’s excellence in neuroscience and molecular biology has earned him numerous accolades, including the Marsh Foundation Research Award (2024) and the prestigious NIH Pathway to Independence Career Development Award (K99/R00, 2020). He received the Best Oral Presentation Award at TTUHSC El Paso’s Annual Research Symposium (2022) and Best Poster Award at the Regional Healthy Aging Symposium (2018). His early career was marked by top-tier fellowships from ICMR, CSIR, and IIT Kanpur. These honors underscore his impactful contributions to aging and neurodegenerative disease research.

📚 Publications

  • Protective effects of Indian spice curcumin against amyloid-β in Alzheimer’s disease
    PH Reddy, M Manczak, X Yin, MC Grady, A Mitchell, S Tonk, CS Kuruva, …
    Year: 2018
    Citations: 367

  • Are circulating microRNAs peripheral biomarkers for Alzheimer’s disease?
    S Kumar, PH Reddy
    Year: 2016
    Citations: 333

  • Mutant APP and amyloid beta-induced defective autophagy, mitophagy, mitochondrial structural and functional changes and synaptic damage in hippocampal neurons from Alzheimer’s disease
    PH Reddy, XL Yin, M Manczak, S Kumar, JA Pradeepkiran, M Vijayan, …
    Year: 2018
    Citations: 292

  • MicroRNAs as peripheral biomarkers in aging and age-related diseases
    S Kumar, M Vijayan, JS Bhatti, PH Reddy
    Year: 2017
    Citations: 234

  • MicroRNA-455-3p as a potential peripheral biomarker for Alzheimer’s disease
    S Kumar, M Vijayan, PH Reddy
    Year: 2017
    Citations: 169

  • A critical evaluation of neuroprotective and neurodegenerative MicroRNAs in Alzheimer’s disease
    PH Reddy, S Tonk, S Kumar, M Vijayan, R Kandimalla, CS Kuruva, …
    Year: 2017
    Citations: 158

  • Defective mitophagy and synaptic degeneration in Alzheimer’s disease: Focus on aging, mitochondria and synapse
    H Morton, S Kshirsagar, E Orlov, LE Bunquin, N Sawant, L Boleng, …
    Year: 2021
    Citations: 142

  • Deregulated mitochondrial microRNAs in Alzheimer’s disease: focus on synapse and mitochondria
    P Gowda, PH Reddy, S Kumar
    Year: 2022
    Citations: 121

  • MicroRNA-455-3p as a potential biomarker for Alzheimer’s disease: an update
    S Kumar, PH Reddy
    Year: 2018
    Citations: 116

  • Are microRNAs true sensors of ageing and cellular senescence?
    J Williams, F Smith, S Kumar, M Vijayan, PH Reddy
    Year: 2017
    Citations: 96

🔚 Conclusion

In conclusion, Dr. Subodh Kumar stands out as a visionary scientist whose pioneering work in Alzheimer’s disease has bridged molecular biology and translational neuroscience. His innovative studies on synaptosomal and mitochondrial miRNAs offer promising avenues for diagnostic and therapeutic advancements. Dr. Kumar’s dedication, scholarly excellence, and translational impact make him a deserving candidate for this award recognition.

Ze Fan | Neuroscience | Best Researcher Award

Published on by Forensic Scientist

Dr. Ze Fan | Neuroscience | Best Researcher Award

Fourth military medical university | China

Dr. Ze Fan is a dedicated Lecturer at the Fourth Military Medical University, specializing in the complex interplay between anesthesia and neuronal metabolism. With a deep-rooted passion for neuroscience and more than 20 SCI-indexed publications, Ze Fan has established a strong academic presence in the field. His work has significantly contributed to understanding how neuronal systems are influenced by external pharmacological factors, with a specific emphasis on astrocyte-neuron interactions.

Professional profile👤

Scopus

Strengths for the Awards✨

Dr. Ze Fan, currently a Lecturer at the Fourth Military Medical University, demonstrates commendable dedication to advancing medical science, specifically in the domains of anesthesia and neuronal metabolism. With 23 SCI-indexed publications and over 400 citations, Ze Fan’s work stands as a significant contribution to neuroanesthesiology. His focus on astrocyte-mediated neuronal function and cognitive behavior in animals addresses critical challenges in neuroscience, and his research outcomes offer promising insights into neuroprotection and anesthetic mechanisms. The completion of 7 independent research projects showcases his capability to lead, manage, and deliver impactful scientific studies.

🎓 Education

Ze Fan pursued his higher education in the medical sciences, laying a robust foundation in anesthesiology and neuroscience. His academic training equipped him with cutting-edge research methodologies and the theoretical knowledge necessary for innovation in neuropharmacology and metabolic studies.

💼 Experience

Currently serving as a Lecturer at the Fourth Military Medical University, Ze Fan has been actively involved in both teaching and research. His career is marked by a persistent focus on laboratory-based investigations and academic mentorship. He brings years of hands-on experience in neural studies, experimental modeling, and cognitive behavior research in animal systems.

🔬 Research Interests On Neuroscience

Ze Fan’s research revolves around anesthesia, neuronal metabolism, and particularly the influence of astrocytes on neuronal function and animal cognitive behaviors. He is driven by the quest to understand how the brain’s metabolic environment alters under the influence of anesthesia and how glial cells contribute to cognitive processes.

🏅 Awards

While this application is for the Best Researcher Award, Ze Fan’s extensive SCI-indexed contributions and high citation count (406 citations) underscore his eligibility. His innovative research continues to attract attention from peers in neuroscience and anesthesiology alike, paving the way for future recognition and academic distinction.

📚 Publications

  1. Effectiveness of dexmedetomidine as a premedication for pediatric patients undergoing outpatient dental surgery under general anaesthesia—systematic review and meta-analysis

    • Authors: Xiao Zhang, Ze Fan, Danyi He, Haopeng Zhang

    • Year: Mar 2025

  2. Glutamatergic Projections from the Basolateral Amygdala to Medial Prefrontal Cortex Contribute to Acute Itch Sensation Processing

    • Authors: Qiuying Zhao, Ze Fan, Yiwen Zhang, Jing Huang

    • Year: Mar 2025

  3. Microglial EPOR Contribute to Sevoflurane-induced Developmental Fine Motor Deficits Through Synaptic Pruning in Mice

    • Authors: Danyi He, Xiaotong Shi, Lirong Liang, Hui Zhang

    • Year: Jun 2024

  4. Fer-1 Protects against Isoflurane-Induced Ferroptosis in Astrocytes and Cognitive Impairment in Neonatal Mice

    • Authors: Peng Zhang, Xiaotong Shi, Danyi He, Ze Fan

    • Year: May 2024

  5. GABAergic neurons in the ventral lateral geniculate nucleus and intergeniculate leaflet modulate itch processing in mice

    • Authors: Yi Liang, Ze Fan, Jiaqi Li, Jing Huang

    • Year: Jun 2023

  6. Integrated ribosome and proteome analysis provides insight into sevoflurane-induced long-term social behavior and cognitive dysfunctions by inhibiting ADNP in neonatal mice

    • Authors: Lirong Liang, Bing Liu, Shuhui Cao, Hui Zhang

    • Year: Jan 2023

  7. Sevoflurane-Induced Neurotoxicity in the Developing Hippocampus via HIPK2/AKT/mTOR Signaling

    • Authors: Lirong Liang, Ze Fan, Danyi He, Hui Zhang

    • Year: Jun 2022

  8. Maternal sevoflurane exposure disrupts oligodendrocyte myelination of the postnatal hippocampus and induces cognitive and motor impairments in offspring

    • Authors: Ze Fan, Lirong Liang, Ruixue Ma, Hui Zhang

    • Year: May 2022

  9. N-myc downstream-regulated gene 2 deficiency aggravates memory impairment in Alzheimer’s disease

    • Authors: Liang Tao, Yuanyuan Zhu, Rui Wang, Yan Li

    • Year: Apr 2022

  10. Taurine Alleviates Chronic Social Defeat Stress-Induced Depression by Protecting Cortical Neurons from Dendritic Spine Loss

    • Authors: Yuanyuan Zhu, Rui Wang, Ze Fan, Sheng-Xi Wu

    • Year: Apr 2022

✅ Conclusion

🧪 With an unwavering commitment to research, Ze Fan has become a rising thought leader in the domain of anesthesia and neuronal metabolism. His contributions—especially in decoding astrocytic influence on brain function—are shaping new paradigms in neurological sciences. His scholarly rigor, impactful publications, and citation footprint make him a strong contender for the Best Researcher Award 🏆.

Qingbao Guo | Neuroscience | Outstanding Scientist Award

Published on by Forensic Scientist

Prof. Qingbao Guo | Neuroscience | Outstanding Scientist Award

Xi’an No.9 Hospital | China

Prof. Qingbao Guo is a highly accomplished Associate Chief Physician in the Department of Neurosurgery at the Second Affiliated Hospital of the Air Force Medical University (formerly Tangdu Hospital), China. He specializes in cerebrovascular disorders, brain tumors, and functional neurosurgery, and is recognized for his excellence in the diagnosis and treatment of moyamoya disease and other complex neurological conditions.

Professional profile👤

ORCID

Scopus

Strengths for the Awards✨

  1. Extensive Clinical Experience:

    • Over 20 years of progressive clinical practice in neurosurgery, including leadership as Associate Chief Physician at a top-tier military hospital.

    • Strong surgical expertise in cerebrovascular diseases, brain tumors, and functional neurosurgery, which are critical areas in modern neurosurgical practice.

  2. Academic Qualifications & Research:

    • A recent Ph.D. in Neurosurgery (2021–2024) focused on moyamoya disease (MMD)—a rare but significant cerebrovascular disorder.

    • Earlier Master’s-level research on peripheral vascular diseases, showing continuity in vascular-focused research.

    • Mentorship under established experts (Professors Lian Duan and Yanzheng He), enhancing academic rigor.

  3. Contribution to National Defense Health System:

    • His long-term service in military medical institutions (Air Force Medical University) underscores contributions to military medicine, a high-impact field with national importance.

  4. Interdisciplinary Relevance:

    • His work bridges clinical practice and surgical innovation, especially in the surgical management of complex neurological diseases, offering translational value to both academic and applied medicine.

🎓 Education

Prof. Qingbao Guo began his academic journey with a Bachelor’s degree in Clinical Medicine from Yan’an University (1999–2004). He furthered his specialization with a Master’s degree in Surgery (2008–2011) from Southwest Medical University, under the supervision of Prof. Yanzheng He, where he focused on clinical approaches to peripheral vascular diseases. Most recently, he earned his Ph.D. in Neurosurgery (2021–2024) from the Chinese PLA Medical School, mentored by Prof. Lian Duan, with research concentrating on the pathogenesis and surgical management of moyamoya disease.

💼 Professional Experience

Prof. Qingbao Guo has an extensive and progressive professional background in neurosurgery. He is currently serving as an Associate Chief Physician at Tangdu Hospital since September 2012, where he has amassed advanced surgical experience in managing brain tumors, vascular pathologies, and functional neurosurgical disorders. Prior to this, he was an Attending Physician at the First Affiliated Hospital of Southwest Medical University (July 2011 – August 2012), where he handled numerous vascular cases. His medical career began as a Resident Physician at Shaanxi Sengong Hospital (July 2004 – August 2008).

🔬 Research Interests On Neuroscience

Prof. Qingbao Guo’s research focuses on the pathophysiology and surgical treatment of cerebrovascular diseases, particularly moyamoya disease, a rare but serious condition affecting intracranial arteries. He is also interested in neuro-oncology, vascular neurosurgery, and advancements in functional neurosurgical procedures, with a vision to bridge translational neuroscience and surgical innovation.

🏆 Awards & Nominations

Prof. Qingbao Guo has been acknowledged for his clinical excellence and academic contribution through multiple hospital-level and regional honors. He is a nominee for the [Insert Award Name Here, e.g., “Outstanding Neurosurgeon Researcher Award 2025”] in recognition of his pioneering work in moyamoya disease surgical treatment and his consistent commitment to patient-centered research and education.

📚 Publications

🔬 Genetic Associations and Polymorphisms

  1. MTHFR Polymorphism and EDAS-induced Collateral Formation

    • [DOI: 10.3171/2024.1.JNS232121]
      Highlights the genetic influence (MTHFR) on surgical angiogenesis success post-EDAS in MMD patients.

  2. RNF213 p.R4810K Variant and Unfavorable Outcomes in Pediatric EDAS

    • [DOI: 10.1155/2024/1844190]
      Strong linkage of the RNF213 mutation with poor long-term outcomes, particularly relevant in East Asian populations.

🧪 Biomarker and Multi-Omics Studies

  1. Proteomic & Metabolomic Profiles in Pediatric MMD

    • [DOI: 10.2147/JIR.S471538]
      Identifies core disrupted pathways, potentially pointing toward new diagnostic or therapeutic targets.

  2. Complement C3 Expression & Postoperative Vasculopathy

    • [DOI: 10.2147/JIR.S451538]
      Suggests inflammatory markers like C3 as predictors of vascular changes post-intervention.

🧠 Neuroimaging and Risk Stratification

  1. MRI Vessel Wall Enhancement and MMD Outcomes

    • [DOI: 10.1007/S00330-023-10535-0]
      High-resolution MRI features were linked to clinical risk, potentially informing preoperative planning.

  2. Nomograms for Predicting Rebleeding and Outcomes

    • [DOI: 10.3171/2024.2.JNS232744]
      Well-validated clinical tools that integrate genetics and clinical features for long-term prognosis.

🧬 Pathophysiology and Comorbid Disease Connections

  1. Transcriptomics in MMD and SLE Crosstalk

    • [DOI: 10.3389/FIMMU.2024.1456392]
      A novel systems biology approach to uncover common pathways between MMD and autoimmune diseases like SLE.

  2. ZEB2 and Brain Microvascular Dysfunction Post-ICH

    • [DOI: 10.1080/15384101.2021.1959702]
      Delves into molecular mechanisms of endothelial dysfunction, bridging stroke and hemorrhage pathology.

📉 Risk Factors in Pediatric and Elderly Cohorts

  1. Preoperative Infarction & Pediatric Risk Factors

    • [DOI: 10.1007/S12975-023-01167-Z]
      Targeted focus on predictive markers in vulnerable pediatric populations.

  2. Outcomes in Elderly Post-Conservative vs. EDAS Treatment

  • [DOI: 10.3171/2023.7.JNS231060]
    Offers insights into age-specific management strategies and long-term care plans.

🔚 Conclusion

Prof. Qingbao Guo stands out as a dedicated neurosurgeon, educator, and researcher, committed to transforming patient outcomes through clinical expertise and scientific inquiry. His extensive training, hands-on experience, and impactful research make him a compelling candidate for any award celebrating excellence in medical and surgical innovation.

Chunxiao Wu | Neuroscience | Best Researcher Award

Published on by Forensic Scientist

Dr. Chunxiao Wu | Neuroscience | Best Researcher Award

Shenzhen Hospital of Integrated Traditional Chinese and Western Medicine | China

Dr. Chunxiao Wu (吴春晓) is a dedicated neuroscientist and clinician with a robust background in traditional Chinese medicine and modern neurological treatment. Currently serving as an Associate Professor at Guangzhou University of Chinese Medicine and a Neurology Doctor at Shenzhen Hospital of Integrated Traditional Chinese and Western Medicine, she is passionate about merging acupuncture-based therapies with scientific rigor to address complex neurological disorders like stroke and Parkinson’s disease. Her work is grounded in both clinical excellence and pioneering research.

Professional profile👤

Scopus

Strengths for the Awards✨

  • Strong Academic Background and Career Progression

    • Dr. Wu has demonstrated consistent academic growth—from a Bachelor’s in Traditional Chinese Medicine to a PhD in Acupuncture, and now holds a position as Associate Professor.

    • Her dual role as a practicing Neurology Doctor and academic gives her research practical relevance and clinical depth.

  • Specialized and Impactful Research Area

    • Her focus on electroacupuncture for ischemic stroke and neurodegenerative disorders (e.g., Parkinson’s Disease) is both niche and highly relevant in today’s integrative medical approaches.

    • Contributions to identifying mechanisms like the NCOA4-FTH1 signaling pathway in ferroptosis add originality and depth.

  • Consistent and High-Quality Publications

    • Over 13 SCI-indexed publications, many in Q1/Q2 journals like Journal of Affective Disorders and Frontiers in Aging Neuroscience.

    • Her studies combine traditional Chinese techniques with modern bioinformatics, clinical trials, and neurochemical investigations, which enhances their scientific value.

  • Strong Research Funding Track Record

    • Principal investigator of two major national-level funded projects (NSFC and China Postdoctoral Foundation).

    • Participation in four additional NSFC projects, showing sustained involvement in collaborative and competitive research.

🎓 Education

Dr. Wu’s academic journey is marked by her deep commitment to the healing arts and medical science. She earned her Bachelor’s degree in Traditional Chinese Medicine (2009–2014) and Master’s in Acupuncture (2014–2017) from Southern Medical University. Her thirst for innovation led her to pursue a PhD in Acupuncture from Guangzhou University of Chinese Medicine (2017–2020), where she specialized in the neurological mechanisms of acupuncture therapy.

🧪 Experience

With over a decade of experience in clinical practice and scientific research, Dr. Wu has consistently advanced in her career. She began as a Postdoctoral Researcher (2020–2022) at Shenzhen Hospital of Integrated Traditional Chinese and Western Medicine, delving into electroacupuncture’s effects on ischemic stroke. Since 2022, she has been serving as a Neurology Doctor at the same hospital, and in 2023, she was appointed Associate Professor at Guangzhou University of Chinese Medicine.

🔬 Research Interests On Neuroscience

Dr. Wu’s research sits at the intersection of electroacupuncture, neurodegeneration, ischemic stroke, and ferroptosis, with a focus on molecular mechanisms such as the NCOA4-FTH1 signaling pathway and super-enhancer regulation. She applies bioinformatics and mixed-treatment comparison analyses to optimize non-pharmacological therapies for Parkinson’s disease and stroke rehabilitation.

🏆 Awards

In recognition of her significant contributions to acupuncture science and neurological rehabilitation, Dr. Wu has received:

  • 🥈 Second Prize – Science and Technology Progress Award, Chinese Society of Ethnographic Medicine

  • 🥈 Second Prize – Science and Technology Award, Guangdong Acupuncture Society

📚 Publications

Dr. Wu is a prolific author with numerous peer-reviewed publications. Her work has been widely cited in the field of integrative neurology:

  • Investigation of Ferroptosis Mechanisms in Ischemic Stroke Treated with Electroacupuncture: Focusing on the NCOA4-FTH1 Signaling Pathway​

    • Authors: Chunxiao Wu, Zhen Xu, Qian Wang, Hong Guo, Xiang He, Yujie Lin, Li Li, Ling Feng, Qian Li, Chunzhi Tang​

    • Publication Year: 2025​

  • Bioinformatics Analysis of Electroacupuncture Treatment for Ischemic Stroke: Exploring Transcriptional Regulatory Mechanisms Mediated by Super-enhancers​

    • Authors: Chunxiao Wu, Qian Wang, Zhen Xu, Cheng Deng, Chunzhi Tang​

    • Publication Year: 2025​

  • Development, Validation, and Visualization of a Novel Nomogram to Predict Depression Risk in Patients with Stroke​

    • Authors: Chunxiao Wu, Shuang Zhu, Qian Wang, Yujie Xu, Xia Mo, Wei Xu, Zhen Xu​

    • Publication Year: 2024​

  • Development, Validation, and Visualization of a Novel Nomogram to Predict Stroke Risk in Patients​

    • Authors: Chunxiao Wu, Zhen Xu, Qian Wang, Shuang Zhu, Min Li, Chunzhi Tang​

    • Publication Year: 2023​

  • Moxibustion Treatment for Parkinson’s Disease: Study Protocol for a Randomized Controlled Trial​

    • Authors: Chunxiao Wu, Lijun Zhao, Yajing Guo, Xue Hao, Yufei Fan, Peng Wu, Jian Han, Qian Li, Xue Wang, Qian Wang, Xia Luo, Ming Zhu​

    • Publication Year: 2023​

  • The Comparative Efficacy of Non-ergot Dopamine Agonist and Potential Risk Factors for Motor Complications and Side Effects from NEDA Use in Early Parkinson’s Disease: Evidence from Clinical Trials​

    • Authors: Chunxiao Wu, Hong Guo, Yujie Xu, Li Li, Xia Li, Chunzhi Tang, Dongsheng Chen, Ming Zhu​

    • Publication Year: 2022​

  • Effects of Aerobic Exercise and Mind-Body Exercise in Parkinson’s Disease: A Mixed-Treatment Comparison Analysis​

    • Authors: Chunxiao Wu, Yujie Xu, Hong Guo, Chunzhi Tang, Dongsheng Chen, Ming Zhu​

    • Publication Year: 2021​

  • Integrated Bioinformatics Analysis of Potential mRNA and miRNA Regulatory Networks in Mice with Ischemic Stroke Treated by Electroacupuncture​

    • Authors: Chunxiao Wu, Lijun Zhao, Xia Li, Yujie Xu, Hong Guo, Zhen Huang, Qian Wang, Hong Liu, Dongsheng Chen, Ming Zhu​

    • Publication Year: 2021​

  • Reply to: Qigong as a Promising Mind-Body Exercise for Cognitive Functioning​

    • Authors: Chunxiao Wu, Chunzhi Tang​

    • Publication Year: 2019​

  • Effects of Mind-Body Exercises on Cognitive Function in Older Adults: A Meta-Analysis​

    • Authors: Chunxiao Wu, Qiang Yi, Xia Zheng, Shoubao Cui, Bing Chen, Lijuan Lu, Chunzhi Tang

    • Publication Year: 2019

🎯 Conclusion

Dr. Chunxiao Wu is a shining example of integrative medical excellence, combining traditional acupuncture techniques with modern neurological insights. Her passion for research, commitment to patient care, and remarkable academic output mark her as an exceptional candidate for any prestigious research award. Her future continues to hold promise as she advances the science of mind-body medicine with impactful clinical research.